← boothcheck

ELV vs UNM stock comparison

ELEVANCE HEALTH, INC. vs Unum Group, two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

No growth figures print here, and the two insurers grow different things anyway: Elevance compounds medical membership at a 2.6% net margin, Unum compounds workplace-benefits premium at 5.9%. The capital efficiency favors the health giant, 11.9% on equity against 7.2%, at seven times the scale. The multiples land within three turns, 16.8 and 19.5 times, dividends within half a point, 1.5% and 2%. What separates the pages is risk vintage: Elevance's exposure is this year's Medicaid rate cycle, Unum's is decades-old long-term-care reserves it has spent years remediating. The market charges slightly more for the reserve story than the rate story, which is a quiet vote for problems that age over problems that repeat.

Comparison updated 2026-07-10.

ELV vs UNM: the numbers

MetricELVUNM
Price$395.20$90.06
Market cap$87.1B$14.8B
SectorManaged CareManaged Care
StageMatureMature
P/E16.819.5
P/B1.981.36
P/S0.431.11
EV/EBITDA17.9
Revenue growth+9.5%+4.4%
Operating margin4.2%
Net margin2.6%5.9%
Return on equity11.9%7.2%
Return on assets4.2%1.3%
Return on invested capital6.2%
FCF yield7.4%3.6%
Dividend yield1.5%1.9%
Debt / equity0.720.35
Current ratio1.48
Altman Z (solvency)2.890.69
Piotroski F (quality)7 / 99 / 9
Full ELV report → Full UNM report →
Get boothcheck's read on ELV and UNM, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.